• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Older

Though agency advisers had some safety concerns, the Pfizer shot is expected to be available before the winter R.S.V. season.

Christina Jewett
Author: Christina Jewett

Written by

Christina Jewett

in

Centers for Disease Control and Prevention, Drugs (Pharmaceuticals), Elderly, Food and Drug Administration, GSK PLC, Guillain-Barre Syndrome, Pfizer Inc, Respiratory Syncytial Virus (RSV), Vaccination and Immunization, Viruses
←Amanda Gorman’s Book Sales Soar Amid Florida Bans Of Her Work
Conservatives Complain Chick-fil-A Has ‘Gone Woke’ Over D.E.I.→

More posts

  • Oracle jumps after Q3 results exceed expectations, boost to sales guidance

  • Stocks close lower in volatile trading session, crude oil falls after trimming steeper losses

  • Ted Cruz, Tucker Carlson reignite feud over Iran war

  • WATCH: Waymo vehicle stops inside railway crossing gate

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube